Avant Genomics Secures $3M+ in Funding for Automated Liquid Biopsy Platform
Avant Genomics has raised over $3 million to enhance the development of the Avant Source™, an innovative automated platform for liquid biopsy sample preparation.
CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Avant Genomics has raised $3+ million to advance development of the Avant Source™, an automated platform for liquid biopsy sample preparation.